Is Lantus causing cancer (carcinogenic) ?

ryanfirstlantusAre you using Lantus for keeping a check on your diabetes? Are you not risking your life with cancer? Well the Canadian Health Ministry have a few doubts to clear.

Full article »

New diabetes drug must ensure not to increase cardiac trouble: FDA

The U.S. Food and Drug Administration has asked all companies to show their diabetes drugs don’t increase chances of cardiac trouble. This new guidance document, announced Wednesday, comes on the heels of reports that two commonly prescribed blood sugar-lowering drugs already on the market, Avandia and Actos, increase the risk of heart failure and, in the case of Avandia, increase the risk of heart attack.

Full article »

Study finds leading diabetes drug can lead to heart disease

Harvard University researchers have found the diabetes drug Avandia can be harmful to heart and can lead to death. The study was led by Dr. Wolfgang Winkelmayer of Brigham and Women’s Hospital in Boston. He and his colleagues reported people aged 65 and older who took Avandia (rosiglitazone) had a 15 percent higher rate of death after an average of one year.

Full article »

Death row over Byetta effcets Amylin shares

It seems that the Amylin Pharmaceuticals Inc.is paying the hard times. After the news of death over the diabetes drug Byetta spreads, the shares of the company, fell.

Full article »

Again Four diabetic patient died due to Byetta

Four more death of the Byetta patient has been reported on Tuesday, 26th August, 2008. This makes count of 6, as on 18th August,2008 FDA announced the death of two people taking this drug.

Full article »

FDA warning for diabetic drug - Byetta

FDAFood and Drug Administration (FDA) has announced a “stronger and more prominent warnings” to the diabetic drug named Byetta. Latest news reveals that since October of 2007 more than six incidents of hemorrhagic or necrotizing pancreatitis in patients have been reported to FDA. Of which two patients have already died.

Full article »

Glumetza (Type 2 Diabetic Drug) Would be Promoted In The U.S Market by Santarus

GlumetzaAccording to the announcement done on 22 of July 2008, by Santarus Inc.(a renowned San Deigo based company), they have signed an agreement with Depomed Inc. to promote Glumetza (a diabetic drug ) in the U.S market.

Full article »

FDA To Discuss The Diabetes Drug Standard In Two Day Meeting

A prominent medical expert, Cardiologist Steven Nissen of the Cleveland Clinic urged the U.S. Food and Drug Administration to raise its standards for approving diabetes drugs on Tuesday. Nissen said that companies need to prove new drugs don’t increase cardiovascular disease, the leading killer of diabetics. Nissen suggested that, in addition to requiring more pre-approval studies, companies should have large, long-term studies in place when a drug is approved to monitor whether the drug increases the risk of cardiovascular disease. He discussed the issue of diabetes drugs standards as a part of a two-day meeting starting Tuesday.

Full article »


Protected by Comment Guard Pro